Featured
-
-
Article
| Open AccessA platform for glycoengineering a polyvalent pneumococcal bioconjugate vaccine using E. coli as a host
Bioconjugation is a promising process to manufacture conjugate vaccines, but currently employed enzymes cannot generate the full spectrum of bacterial glycoproteins. Here, the authors use an O-linking oligosaccharyltransferase to generate a polyvalent pneumococcal bioconjugate vaccine with polysaccharides containing glucose at their reducing end.
- Christian M. Harding
- , Mohamed A. Nasr
- & Mario F. Feldman